Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2025-12-25 @ 4:46 PM
NCT ID:
NCT03710603
Group ID:
EG001
Title:
Daratumumab + VRd (D-VRd)
Description:
Arm B: Patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplantation were treated with subcutaneous daratumumab in combination with bortezomib, lenalidomide, and dexamethasone for induction and consolidation followed by subcutaneous daratumumab in combination with lenalidomide maintenance in 28-day cycles. After 4 cycles of induction, patients received high dose therapy with autologous stem cell transplantation.
Deaths Number Affected:
34
Deaths Number At Risk:
None
Serious Number Affected:
200
Serious Number At Risk:
351
Other Number Affected:
348
Other Number At Risk:
351
Study:
NCT03710603
Results Section:
NCT03710603
Adverse Events Module:
NCT03710603